Dapagliflozin
medicationSGLT2 inhibitor (brand name: Farxiga) for type 2 diabetes and heart failure. May have longevity and metabolic benefits.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Dapagliflozin to your stack to report effects
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1βyear.
Not specified in available data
The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Patients With T2DM
Not specified in available data
No reports yet
Be the first to report this effect and help the community.
Add Dapagliflozin to your stack to report effects
The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Patients With T2DM
Not specified in available data
No reports yet
Be the first to report this effect and help the community.
Add Dapagliflozin to your stack to report effects
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1βyear.
Not specified in available data
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Dapagliflozin to your stack to report effects
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1βyear.
Not specified in available data
No reports yet
Be the first to report this effect and help the community.
Add Dapagliflozin to your stack to report effects
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1βyear.
Not specified in available data
Research (2 studies)
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1βyear.
Not specified in available data
The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Patients With T2DM
Not specified in available data
Community updates
No updates yet for this supplement.
Be the first to share your experience!